medicina47巻13号

2010年12月発行

今月の主題 これ血液悪性疾患？自分の守備範囲？―非専門医のための見分け方 血液悪性疾患の疫学と分類

白血病の分類

著者： 鈴木律朗¹

所属機関： ¹名古屋大学大学院医学系研究科造血細胞移植情報管理・生物統計学

ページ範囲：P.2114 - P.2124

ポイント

★血液腫瘍の分類は「白血病かリンパ腫か」でなく，「骨髄性かリンパ性か」という由来細胞に基づく分類に移行しつつある．

★遺伝子異常によって分類する動きが加速している．

参考文献

1）Bennett JM, et al；French-American-British（FAB）co-operative group：Proposals for the classification of the acute leukaemias. Br J Haematol 33：451-458, 1976

2）Bennett JM, et al；French-American-British（FAB）Cooperative Group：Proposals for the classification of chronic（mature）B and T lymphoid leukaemias. J Clin Pathol 42：567-584, 1989

3）Bennett JM, et al；Proposals by the French-American-British Cooperative Leukaemia Group：The chronic myeloid leukaemias；Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Br J Haematol 87：746-754, 1994

4）Jaffe ES, et al：Tumours of Haematopoietic and Lymphoid Tissues, IARC, Lyon, 2001

5）Swerdlow SH, et al：WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC, Lyon, 2008

positive. Swerdlow SH, et al（eds）：WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp 32-37, IARC, Lyon, 2008

genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348：1201-1214, 2003

8）Bennett JM, et al：Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51：189-199, 1982

9）Golub TR, et al：Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t（5；12）chromosomal translocation. Cell 77：307-316, 1994

10）Inhorn RC, et al：A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t（8；13）（p11；q11）；Description of a distinctive clinicopathologic entity. Blood 85：1881-1887, 1995

11）Willemze R, et al：WHO-EORTC classification for cutaneous lymphomas. Blood 105：3768-3785, 2005

12）Garnache-Ottou F, et al：Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 105：1256-1264, 2005

13）Chaperot L, et al：Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97：3210-3217, 2001

14）O'Doherty U, et al：Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 178：1067-1076, 1993

15）Slovak ML, et al：Karyotypic analysis predicts outcome of pre-remission and post remission therapy in adult acute myeloid leukemia；A Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96：4075-4083, 2000

16）Grimwade D, et al：The importance of diagnostic cytogenetics on outcome in AML；Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92：2322-2333, 1998

17）Raghavachar A, et al：Acute undifferentiated leukemia；Implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement. Blood 68：658-662, 1986

18）Neame PB, et al：Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. Blood 65：142-148, 1995

19）Chan JKC, Jaffe ES, Ralfkiaer E：Blastic NK-cell lymphoma. Jaffe ES, et al（eds）：World Health Organization Classification of Tumours；Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, pp 214-215, IARC Press, Lyon, 2001

20）Borowitz MJ, et al：Acute leukemia of ambiguous lineage. Swerdlow SH, et al（eds）：WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp 150-155, IARC, Lyon, 2008

21）Suzuki R, et al：CD7＋ and CD56＋ myeloid/NK cell precursor acute leukemia；A distinct hematolymphoid disease entity. Blood 90：2417-2428, 1997

22）Quintanilla-Martinez L, et al：Fulminant EBV（＋）T-cell lymphoproliferative disorder following acute/chronic EBV infection；A distinct clinicopathologic syndrome. Blood 96：443-451, 2000

23）Kimura H, et al；Japanese Association for Research on Epstein-Barr Virus and Related Diseases：Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187：527-533, 2003

24）Suzuki R, et al, and the NK-cell Tumor Study Group：Aggressive natural killer-cell leukemia revisited；Large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18：763-770, 2004

25）Tefferi A, et al：Chronic natural killer cell lymphocytosis；A descriptive clinical study. Blood 84：2721-2725, 1994